Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Chronic Myelogenous Leukemia With Nephrotic Syndrome

Chronic Myelogenous Leukemia With Nephrotic Syndrome Abstract • A patient with chronic myelogenous leukemia was initially seen with nephrotic syndrome. Minimal-change glomerulonephritis was verified by open renal biopsy, and the patient showed good response to treatment with a diuretic and prednisone. We believe this represents the first reported case of nephrotic syndrome in myelogenous leukemia. (Arch Intern Med 1983;143:168-169) References 1. Gagliano RG, Costanzi JJ, Beathard GA, et al: The nephrotic syndrome associated with neoplasia: An unusual paraneoplastic syndrome. Am J Med 1976;60:1026-1031.Crossref 2. Eagen JW, Lewis EJ: Glomerulopathies of neoplasia. Kidney Int 1977;11:297-306.Crossref 3. Fer MR, McKinney TD, Richardson RL, et al: Cancer and the kidney: Renal complication of neoplasm. Am J Med 1981;71:704-718.Crossref 4. Muggia FM, Heinemann HO, Farhangi M, et al: Lysozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemia. Am J Med 1969;47:351-366.Crossref 5. Pruzanski W: Serum and urinary proteins and renal function in chronic myelogenous leukemia. Am J Med Sci 1972;263:163-171.Crossref 6. Mir MA, Delamore IW: Metabolic disorders in acute myeloid leukemia. Br J Haematol 1978;40:79-92.Crossref 7. Agorwal RG, Gupta KD, Bharadwaj TP: Nephrotic syndrome in the possible terminal blast-cell crisis in myeloid leukemia. J Assoc Physicians India 1972;20:799-801. 8. Shalholub RJ: Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 1974;2:556-559.Crossref 9. Ooi BS, Orlina AR, Masaitis L: Lymphocytotoxins in primary renal disease. Lancet 1972;2:1348-1350. 10. Beutler E, Blume KG: Terminal deoxynucleotidyl transferase: Biochemical properties, cellular distribution, and hematological significance , in Brown EB (ed): Progress in Hematology . New York, Grune & Stratton Inc, 1979, p 47. 11. Lowenstein J, Schacht RG, Baldwin DS: Renal failure in minimal change nephrotic syndrome. Am J Med 1981;70:227-233.Crossref 12. Llach F, Papper S, Massry SG: The clinical spectrum of renal vein thrombosis: Acute and chronic. Am J Med 1980;69:918-927.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

Chronic Myelogenous Leukemia With Nephrotic Syndrome

Loading next page...
 
/lp/american-medical-association/chronic-myelogenous-leukemia-with-nephrotic-syndrome-HpiDAGWB5t
Publisher
American Medical Association
Copyright
Copyright © 1983 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinte.1983.00350010180036
Publisher site
See Article on Publisher Site

Abstract

Abstract • A patient with chronic myelogenous leukemia was initially seen with nephrotic syndrome. Minimal-change glomerulonephritis was verified by open renal biopsy, and the patient showed good response to treatment with a diuretic and prednisone. We believe this represents the first reported case of nephrotic syndrome in myelogenous leukemia. (Arch Intern Med 1983;143:168-169) References 1. Gagliano RG, Costanzi JJ, Beathard GA, et al: The nephrotic syndrome associated with neoplasia: An unusual paraneoplastic syndrome. Am J Med 1976;60:1026-1031.Crossref 2. Eagen JW, Lewis EJ: Glomerulopathies of neoplasia. Kidney Int 1977;11:297-306.Crossref 3. Fer MR, McKinney TD, Richardson RL, et al: Cancer and the kidney: Renal complication of neoplasm. Am J Med 1981;71:704-718.Crossref 4. Muggia FM, Heinemann HO, Farhangi M, et al: Lysozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemia. Am J Med 1969;47:351-366.Crossref 5. Pruzanski W: Serum and urinary proteins and renal function in chronic myelogenous leukemia. Am J Med Sci 1972;263:163-171.Crossref 6. Mir MA, Delamore IW: Metabolic disorders in acute myeloid leukemia. Br J Haematol 1978;40:79-92.Crossref 7. Agorwal RG, Gupta KD, Bharadwaj TP: Nephrotic syndrome in the possible terminal blast-cell crisis in myeloid leukemia. J Assoc Physicians India 1972;20:799-801. 8. Shalholub RJ: Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 1974;2:556-559.Crossref 9. Ooi BS, Orlina AR, Masaitis L: Lymphocytotoxins in primary renal disease. Lancet 1972;2:1348-1350. 10. Beutler E, Blume KG: Terminal deoxynucleotidyl transferase: Biochemical properties, cellular distribution, and hematological significance , in Brown EB (ed): Progress in Hematology . New York, Grune & Stratton Inc, 1979, p 47. 11. Lowenstein J, Schacht RG, Baldwin DS: Renal failure in minimal change nephrotic syndrome. Am J Med 1981;70:227-233.Crossref 12. Llach F, Papper S, Massry SG: The clinical spectrum of renal vein thrombosis: Acute and chronic. Am J Med 1980;69:918-927.Crossref

Journal

Archives of Internal MedicineAmerican Medical Association

Published: Jan 1, 1983

References